HDFC Innovation Fund vs SBI Healthcare Opportunities Fund

Portfolio Overlap Analysis · HDFC vs SBI

16.1%
Low Overlap
8 common stocks · Rank #14193 of 28,292 pairs
Fund A
HDFC Innovation Fund
HDFC · Equity - Other
Fund B
SBI Healthcare Opportunities Fund
SBI · Sectoral - Pharma

Common Holdings (8)

StockWt% in HDFC InnovationWt% in SBI Healthcare OpportunitiesOverlap
Divi's Laboratories Ltd.
Pharmaceuticals & Biotechnology
7.55%4.33%4.33%
Torrent Pharmaceuticals Ltd.
Pharmaceuticals & Biotechnology
4.25%2.66%2.66%
Sun Pharmaceutical Industries Ltd.
Pharmaceuticals & Biotechnology
10.65%2.56%2.56%
Laurus Labs Ltd.
Pharmaceuticals & Biotechnology
3.48%2.09%2.09%
Sai Life Sciences Ltd.
Pharmaceuticals & Biotechnology
1.96%1.61%1.61%
Anthem Biosciences Ltd.
Pharmaceuticals & Biotechnology
2.68%1.30%1.30%
Lupin Ltd.
Pharmaceuticals & Biotechnology
4.23%1.26%1.26%
Sudeep Pharma Ltd.
Pharmaceuticals & Biotechnology
2.13%0.29%0.29%

Unique to HDFC Innovation

  • Eternal Limited8.98%
  • Bajaj Finance Ltd.5.12%
  • Bharat Electronics Ltd.4.38%
  • PB Fintech Limited4.25%
  • Mahindra & Mahindra Ltd.3.72%
  • Reliance Industries Ltd.3.42%
  • INFO EDGE (INDIA) LIMITED2.83%
  • LENSKART SOLUTIONS LIMITED2.60%

Unique to SBI Healthcare Opportunities

  • Apollo Hospitals Enterprise Ltd.5.76%
  • Max Healthcare Institute Ltd.4.82%
  • Acutaas Chemicals Ltd.4.77%
  • Aster DM Healthcare Ltd.3.85%
  • Biocon Ltd.3.59%

Sector Overlap Breakdown

Pharmaceuticals & Biotechnology
16.1% (8)

Analysis

AI-generated comparative analysis coming soon.

More comparisons for HDFC Innovation

More comparisons for SBI Healthcare Opportunities

Overlap calculated on equity holdings only. Debt, government securities, and cash are excluded.